All lobbying filings
Talley Strategies LLC
Talley Strategies LLC filed a Q3 report for Teva Pharmaceuticals USA, Inc. on October 20, 2025, reporting $40,000 in lobbying income.
Lobbying for Teva Pharmaceuticals USA, Inc. · Pharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbyists on this filing
1
-
AMBER TALLEY New on this filingPreviously held: Senior Counsel/Investigator, Senate Special Committee on Aging; Legislative Director, Chief of Staff, Rep. Jason Chaffetz; Counsel, House Oversight Committee
Government bodies contacted
3
Lobbying activity
2
Issues related to pharmaceutical drug pricing (no specific legislation).
Issues related to pharmaceutical drug pricing (no specific legislation).